PMC:7094172 / 19381-19585 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T731","span":{"begin":38,"end":47},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T730","span":{"begin":56,"end":64},"obj":"SP_9"},{"id":"T729","span":{"begin":105,"end":113},"obj":"SP_9"}],"text":"Figure 4 Compound P3 was a potential inhibitor against MERS-CoV. (A, B) Viral titers (A) and RNA (B) of MERS-CoV measured by plaque assay and RT-qPCR, respectively, decreased after P3 treatment for 48 h."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T112","span":{"begin":94,"end":97},"obj":"Body_part"}],"attributes":[{"id":"A112","pred":"fma_id","subj":"T112","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"Figure 4 Compound P3 was a potential inhibitor against MERS-CoV. (A, B) Viral titers (A) and RNA (B) of MERS-CoV measured by plaque assay and RT-qPCR, respectively, decreased after P3 treatment for 48 h."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T137","span":{"begin":26,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T138","span":{"begin":67,"end":68},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T139","span":{"begin":70,"end":71},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T140","span":{"begin":87,"end":88},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T141","span":{"begin":99,"end":100},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T142","span":{"begin":199,"end":201},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"}],"text":"Figure 4 Compound P3 was a potential inhibitor against MERS-CoV. (A, B) Viral titers (A) and RNA (B) of MERS-CoV measured by plaque assay and RT-qPCR, respectively, decreased after P3 treatment for 48 h."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T157","span":{"begin":38,"end":47},"obj":"Chemical"}],"attributes":[{"id":"A157","pred":"chebi_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Figure 4 Compound P3 was a potential inhibitor against MERS-CoV. (A, B) Viral titers (A) and RNA (B) of MERS-CoV measured by plaque assay and RT-qPCR, respectively, decreased after P3 treatment for 48 h."}

{"project":"LitCovid-sentences","denotations":[{"id":"T153","span":{"begin":0,"end":204},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure 4 Compound P3 was a potential inhibitor against MERS-CoV. (A, B) Viral titers (A) and RNA (B) of MERS-CoV measured by plaque assay and RT-qPCR, respectively, decreased after P3 treatment for 48 h."}

{"project":"LitCovid-PubTator","denotations":[{"id":"323","span":{"begin":56,"end":64},"obj":"Species"},{"id":"324","span":{"begin":105,"end":113},"obj":"Species"}],"attributes":[{"id":"A323","pred":"tao:has_database_id","subj":"323","obj":"Tax:1335626"},{"id":"A324","pred":"tao:has_database_id","subj":"324","obj":"Tax:1335626"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure 4 Compound P3 was a potential inhibitor against MERS-CoV. (A, B) Viral titers (A) and RNA (B) of MERS-CoV measured by plaque assay and RT-qPCR, respectively, decreased after P3 treatment for 48 h."}